PT-141: The Libido-Enhancing Peptide

PT-141 (Bremelanotide) – A peptide therapy designed to support sexual wellness by acting on the central nervous system to influence arousal and desire pathways. Commonly used to help enhance libido and sexual responsiveness in both men and women. Typically administered as needed, a few hours before sexual activity, based on individual response and clinical guidance.

Category:
  • Libido
  • Erectile Dysfunction

Discover PT-141, a remarkable peptide known for its potential to enhance sexual desire and improve sexual function. PT-141, also known as Bremelanotide, is a synthetic peptide developed to address sexual dysfunction in both men and women.

This peptide acts on the central nervous system, specifically targeting receptors involved in sexual arousal and desire. By activating these receptors, PT-141 can help increase libido and enhance sexual satisfaction.

PT-141 has shown promising results in clinical trials, demonstrating improvements in sexual desire, arousal, and overall sexual experience. It has the potential to benefit individuals experiencing various forms of sexual dysfunction, including erectile dysfunction and hypoactive sexual desire disorder.

Unlike traditional medications, PT-141 does not work through hormonal pathways and has a different mechanism of action. It offers a unique approach to sexual wellness by directly targeting the neurochemical pathways involved in sexual arousal.

Treatment Cycle: 8 times/month
Timing of dose: 1-5 hrs before intercourse

Shopping Cart
Scroll to Top